ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.350,38
0,92%
S&P 500
5.996,66
1,00%
US Dollar vs BRL
6,08068
0,00%
Bitcoin
103.266,20
-0,83%
Brent Oil
80,005
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Praxis Precision Medicines Inc (PRAX)

  7. Praxis Precision Medicines Inc (PRAX) Notícias

PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRAX
DataHoraFonteTítuloCódigoCompanhia
14/01/202520:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
23/12/202418:13Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PRAXPraxis Precision Medicines Inc
14/11/202419:50Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
14/11/202416:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
08/11/202416:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PRAXPraxis Precision Medicines Inc
06/11/202409:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
06/11/202409:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
26/09/202409:00GlobeNewswire Inc.Praxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International CongressNASDAQ:PRAXPraxis Precision Medicines Inc
10/06/202417:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRAXPraxis Precision Medicines Inc
12/04/202409:00GlobeNewswire Inc.Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual MeetingNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202411:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202409:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202409:12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PRAXPraxis Precision Medicines Inc
14/02/202422:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
12/01/202419:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
10/01/202418:19GlobeNewswire Inc.Praxis Precision Medicines, Inc. Announces Proposed Public OfferingNASDAQ:PRAXPraxis Precision Medicines Inc
28/11/202309:00GlobeNewswire Inc.Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming MeetingsNASDAQ:PRAXPraxis Precision Medicines Inc
21/11/202318:00GlobeNewswire Inc.Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202310:00GlobeNewswire Inc.Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental EpilepsiesNASDAQ:PRAXPraxis Precision Medicines Inc
07/11/202309:00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
02/11/202309:00GlobeNewswire Inc.Praxis Precision Medicines to Present at Truist Securities BioPharma SymposiumNASDAQ:PRAXPraxis Precision Medicines Inc
16/10/202308:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
04/10/202308:56Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
02/10/202314:17GlobeNewswire Inc.Praxis Precision Medicines Provides Portfolio Update at 2023 R&D DayNASDAQ:PRAXPraxis Precision Medicines Inc
27/09/202317:15GlobeNewswire Inc.Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023NASDAQ:PRAXPraxis Precision Medicines Inc
19/09/202311:25AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:PRAXPraxis Precision Medicines Inc
07/09/202309:00GlobeNewswire Inc.Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
31/08/202309:00GlobeNewswire Inc.Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy CongressNASDAQ:PRAXPraxis Precision Medicines Inc
09/08/202308:00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
08/08/202308:00GlobeNewswire Inc.Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for UlixacaltamideNASDAQ:PRAXPraxis Precision Medicines Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRAX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AMOB3
Automob Participacoes ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
PMAM3
PARANAPANEMA ON
BOV
COGN3
COGNA ON
BOV
BRAV3
Brava Energia ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
AMER3
Americanas ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados